These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20043943)

  • 1. Protective effect of rofecoxib and nimesulide against intra-striatal quinolinic acid-induced behavioral, oxidative stress and mitochondrial dysfunctions in rats.
    Kalonia H; Kumar P; Kumar A; Nehru B
    Neurotoxicology; 2010 Mar; 31(2):195-203. PubMed ID: 20043943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Licofelone attenuates quinolinic acid induced Huntington like symptoms: possible behavioral, biochemical and cellular alterations.
    Kalonia H; Kumar P; Kumar A
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):607-15. PubMed ID: 21237233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor-Upsilon (PPARUpsilon) in Huntington's disease.
    Kalonia H; Kumar P; Kumar A
    Pharmacol Biochem Behav; 2010 Aug; 96(2):115-24. PubMed ID: 20450929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative neuroprotective profile of statins in quinolinic acid induced neurotoxicity in rats.
    Kalonia H; Kumar P; Kumar A
    Behav Brain Res; 2011 Jan; 216(1):220-8. PubMed ID: 20696189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of preferential cyclooxygenase-2 (COX-2) inhibitor against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced striatal lesions in rats: behavioral, biochemical and histological evidences.
    Gupta A; Dhir A; Kumar A; Kulkarni SK
    Indian J Exp Biol; 2010 Jun; 48(6):577-85. PubMed ID: 20882760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effect of MK-801 against intra-striatal quinolinic acid induced behavioral, oxidative stress and cellular alterations in rats.
    Kalonia H; Kumar P; Nehru B; Kumar A
    Indian J Exp Biol; 2009 Nov; 47(11):880-92. PubMed ID: 20099461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galantamine potentiates the protective effect of rofecoxib and caffeic acid against intrahippocampal Kainic acid-induced cognitive dysfunction in rat.
    Kumar A; Prakash A; Pahwa D
    Brain Res Bull; 2011 May; 85(3-4):158-68. PubMed ID: 21439356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-Allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats.
    Pérez-Severiano F; Rodríguez-Pérez M; Pedraza-Chaverrí J; Maldonado PD; Medina-Campos ON; Ortíz-Plata A; Sánchez-García A; Villeda-Hernández J; Galván-Arzate S; Aguilera P; Santamaría A
    Neurochem Int; 2004 Dec; 45(8):1175-83. PubMed ID: 15380627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain.
    Kumar P; Kumar A
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):100-8. PubMed ID: 19022325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms.
    Kumar P; Padi SS; Naidu PS; Kumar A
    Fundam Clin Pharmacol; 2007 Jun; 21(3):297-306. PubMed ID: 17521299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of cyclooxygenase (COX)-inhibitors against drug-induced catatonia and MPTP-induced striatal lesions in rats.
    Gupta A; Dhir A; Kumar A; Kulkarni SK
    Pharmacol Biochem Behav; 2009 Dec; 94(2):219-26. PubMed ID: 19666045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of montelukast against quinolinic acid/malonic acid induced neurotoxicity: possible behavioral, biochemical, mitochondrial and tumor necrosis factor-α level alterations in rats.
    Kalonia H; Kumar P; Kumar A; Nehru B
    Neuroscience; 2010 Nov; 171(1):284-99. PubMed ID: 20813166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressing inflammatory cascade by cyclo-oxygenase inhibitors attenuates quinolinic acid induced Huntington's disease-like alterations in rats.
    Kalonia H; Kumar A
    Life Sci; 2011 Apr; 88(17-18):784-91. PubMed ID: 21362433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
    Kumar P; Kumar A
    Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spermine attenuates behavioral and biochemical alterations induced by quinolinic acid in the striatum of rats.
    Velloso NA; Dalmolin GD; Fonini G; Gindri Sinhorin VD; Ferreira da Silveira A; Rubin MA; Mello CF
    Brain Res; 2008 Mar; 1198():107-14. PubMed ID: 18243165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of caffeic acid and rofecoxib and their combination against intrastriatal quinolinic acid induced oxidative damage, mitochondrial and histological alterations in rats.
    Kalonia H; Kumar P; Kumar A; Nehru B
    Inflammopharmacology; 2009 Aug; 17(4):211-9. PubMed ID: 19633993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III).
    Pérez-De La Cruz V; González-Cortés C; Galván-Arzate S; Medina-Campos ON; Pérez-Severiano F; Ali SF; Pedraza-Chaverrí J; Santamaría A
    Neuroscience; 2005; 135(2):463-74. PubMed ID: 16111817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of naproxen (non-selective COX-inhibitor) or rofecoxib (selective COX-2 inhibitor) on immobilization stress-induced behavioral and biochemical alterations in mice.
    Dhir A; Padi SS; Naidu PS; Kulkarni SK
    Eur J Pharmacol; 2006 Mar; 535(1-3):192-8. PubMed ID: 16522321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting oxidative stress attenuates malonic acid induced Huntington like behavioral and mitochondrial alterations in rats.
    Kalonia H; Kumar P; Kumar A
    Eur J Pharmacol; 2010 May; 634(1-3):46-52. PubMed ID: 20188726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide.
    Kumar P; Kumar A
    Behav Brain Res; 2010 Jan; 206(1):38-46. PubMed ID: 19716383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.